Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Energy Fuels to buy Germany's VAC as rare earths magnet race heats up Rare earths producer Energy Fuels will buy Germany's Vacuumschmelze in ‌a $1.9 billion cash-and-stock deal to become one of the ...

Former Tory minister Peter Bone has become the latest MP to lose the whip after being found to have committed "varied acts of bullying and one act of sexual misconduct" against a staff member. Losing ...

Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Learn about the media sentiment score. Each ...

Beam Therapeutics (BEAM) has submitted 334+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above. When does Beam Therapeutics typically file ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.